Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New antitumor agents synthesized by Kyowa Hakko Kirin

Aug. 19, 2011

Dual FGF/VEGF pathway inhibitor shows promise in limiting tumor resistance to VEGF inhibition

Aug. 18, 2011

Roche obtains FDA approval for melanoma drug and companion diagnostic

Aug. 18, 2011

New prodrugs of proteasome inhibitors designed by Cephalon

Aug. 18, 2011

Allos Therapeutics begins phase III registration trial of Folotyn

Aug. 18, 2011

Emergent BioSolutions begins trial of TRU-016 in relapsed, indolent lymphoma

Aug. 18, 2011

Clavis reports interim results from phase II trial of elacytarabine/idarubicin combination

Aug. 17, 2011

Genetically altered T cells eradicate chronic lymphocytic leukemia cells in patients

Aug. 17, 2011

Acetylon Pharmaceuticals prepares novel HD6 inhibitors

Aug. 17, 2011

New agent exploits Warburg effect and shows promise in renal cell cancer models

Aug. 17, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...